Release Date: 04/09/18 08:24 Summary: Bombora continues to grow Price Sensitive: Yes Download Document 622.53KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%